New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN From The Last 14 Days
Check below for free stories on AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
July 22, 2014
16:36 EDTMCDOn The Fly: Closing Wrap
Subscribe for More Information
13:46 EDTAETCourt upholds Obamacare subsidies, NY Times says
Subscribe for More Information
12:29 EDTMCDOn The Fly: Midday Wrap
Subscribe for More Information
11:50 EDTMCDMcDonald's sees 4c-5c negative impact on EPS from currency in 2014
Subscribe for More Information
11:26 EDTMCDMcDonald's sees minimal impact on Q3 EPS from currency exchange
Subscribe for More Information
11:25 EDTMCDMcDonald's sees U.S. commodity costs up 1%-2% in 2014
Says first priority of cash is to invest in business. Says will be "disciplined" with price increases. Sees U.S. labor cost pressure in 2H.
11:12 EDTMCDMcDonald's doesn't see any material changes to operating environment in 2H
Doesn't see any material changes to operating environment in 2H. Says "no silver bullet" to improve results, but says pushing forward on multiple fronts. Says may bring in new ad agencies. Says moving with a "sense of urgency," but will take time to see results. Sees continued volatility across markets in 2H. Comments made on the Q2 earnings conference call.
10:48 EDTATHNOptions with decreasing implied volatility
Options with decreasing implied volatility: IGT YHOO LYK ATHN CMG SWKS NFLX SHPG SNDK MTG
10:43 EDTAETAppeals court bars subsidies in health care law
A three-judge panel of the D.C. Circuit Court of Appeals struck down part of President Obama's healthcare law by siding today with plaintiffs who argued that the law barred the government from giving subsidies to people in states that chose not to set up their own insurance marketplaces. The appeals court stated, "Because we conclude that the ACA unambiguously restricts the section 36B subsidy to insurance purchased on Exchanges 'established by the State,' we reverse the district court and vacate the IRSís regulation." Twenty-seven states decided against setting up marketplaces, and another nine states partially opted out, according to the Washington Post.
09:36 EDTMCDActive equity options trading on open
Subscribe for More Information
09:08 EDTMCDOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Chipotle (CMG), up 10.7%... Crocs (CROX), up 5%... Lockheed Martin (LMT), up 1.4%. ALSO HIGHER: GreenHunter Resources (GRH), up 10.3% after announcing intent to form MLP... TG Therapeutics (TGTX), up 9.5% after reporting Q2 results, preclinical study results, price target on shares raised to $19 from $13 at Brean Capital... FuelCell (FCEL), up 5.4% after announcing German government support, EUR 4.9M in research awards... Apache (APA), up 5.2% after Bloomberg says activist investor JANA Partners disclosed $1B position in the stock. DOWN AFTER EARNINGS: Harley-Davidson (HOG), down 4.1%... Travelers (TRV), down 3.4%... McDonald's (MCD), down 2.3%... Coca-Cola (KO), down 2.5%. ALSO LOWER: Amazon.com (AMZN), down 1% following downgrade to Neutral rating at Citigroup.
08:15 EDTMCDMcDonald's CEO: Near-term results expected to remain muted
Subscribe for More Information
08:00 EDTMCDMcDonald's reports Q2 global comparable sales relatively flat
Subscribe for More Information
07:58 EDTMCDMcDonald's reports Q2 EPS $1.40, consensus $1.44
Subscribe for More Information
06:43 EDTMCDChina food scandal expands, ropes-in Starbucks, others, Reuters says
Subscribe for More Information
05:21 EDTRHHBYRoche announces Genentech Avastin granted priority review by FDA
Subscribe for More Information
July 21, 2014
17:50 EDTMCDMcDonald's stock doesn't look ready for gains, Barron's says
Subscribe for More Information
16:22 EDTMCDOn The Fly: Closing Wrap
Stocks on Wall Street began the trading day in negative territory and remained there through nearly the whole session. The market action was influenced more by the geopolitical events in Russia and Israel than by the upcoming avalanche of earnings scheduled for release throughout the week. Despite the weak open and subsequent drop during the first hour of trading, the market drifted off its lows and managed to pare its losses, even turning mixed for a short time. The averages dipped again heading into the bell, though they closed well of their worst levels. ECONOMIC EVENTS: In the U.S., the Chicago Fed's National Activity Index dipped to 0.12 in June from a reading of 0.16 in May. COMPANY NEWS: Allergan (AGN) rose $3.74, or 2.23%, to $171.14 after the company's Q2 results and its FY14 outlook beat expectations. The company, which is working to fend off a proposed acquisition by Valeant Pharmaceuticals (VRX), also announced plans to cut its workforce by 13%, or about 1,500 employees, as part of a broader restructuring effort. In related news, Valeant announced it has contacted both the SEC and Canadian financial authorities regarding Allergan's "apparent attempt to mislead investors and manipulate the market for Valeant common shares by continuing to make false and misleading statements regarding Valeant's business." Later in the day, Bill Ackman of Pershing Square, who is partnering with Valeant in its attempt to buy Allergan, called the restructuring a "Valeant light" effort and said Valeant does not need to raise its bid for Allergan. Ackman explained that he believes that shares of Valeant will rise around $10 should the Allergan board engage in takeover talks with the company and that a $10 share rise would boost Valeant's bid for Allergan by $8 per share. MAJOR MOVERS: Among the notable gainers was Extreme Networks (EXTR), which rose 69c, or 15.79%, to $5.06 after the company raised its Q4 earnings per share outlook and narrowed its Q4 revenue view. Also higher were shares of EMC (EMC), which advanced $1.35, or 5.0%, to $28.33 after the Wall Street Journal reported, citing sources, that activist investor Elliott Management has taken a stake of over $1B in the data-storage company and plans to push it to break itself up and spin off VMware (VMW), which is 80% owned by EMC. Shares of VMware fell $2.36, or 2.48%, to $92.95 following the Journal's report. Among the other noteworthy losers was Monster Beverage (MNST), which fell $3.07, or 4.53%, to $64.74 after Morgan Stanley downgraded the stock, citing slowing U.S. trends and balanced valuation. Also lower were shares of Yum! Brands (YUM), which fell $3.29, or 4.25%, to $74.13 after Associated Press reported that the company's KFC brand and McDonald's (MCD) were sold expired beef and chicken in China from food supplier Husi Food. Shares of McDonald's, which is scheduled to report on its quarter before tomorrow's market open, slid $1.44, or 1.45%, to $97.55. INDEXES: The Dow fell 48.45, or 0.28%, to 17,051.73, the Nasdaq dropped 7.44, or 0.17%, to 4,424.70, and the S&P 500 declined 4.59, or 0.23%, to 1,973.63.
15:30 EDTMCDNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Verizon (VZ), consensus 90c; Coca-Cola (KO), consensus 63c; Comcast (CMCSA), consensus 72c; United Technologies (UTX), consensus $1.70; McDonald's (MCD), consensus $1.44; Altria Group (MO), consensus 66c; du Pont (DD), consensus $1.17; Lockheed Martin (LMT), consensus $2.66; Kimberly-Clark (KMB), consensus $1.50; Travelers (TRV), consensus $2.07; Ingersoll-Rand (IR), consensus $1.11; State Street (STT), consensus $1.26; TD Ameritrade (AMTD), consensus 34c; Harley-Davidson (HOG), consensus $1.46; Polaris Industries (PII), consensus $1.39; Crocs (CROX), consensus 31c.
15:22 EDTMCDMcDonald's technical comments before results
In the last three months the shares have traded essentially flat, off of the life high set at $103.78 earlier in the period. On a longer term basis the shares have had difficulty maintaining price above the $100 level. Going back to January 2012 there have been three distinct times this level has been attempted which have all failed. We could be seeing major topping action in the stock. How shares behave now will be critical for the next move. On stronger fundamental news, there could be a test to the old high that holds and gets built upon. That would require the shares take out at least the $105 area on the upside without retracing below $100 thereafter. On weaker news than expected the stock could enter a major decline given these three tops above $100. Triple tops often see deeper corrections follow. Support below the current price of $97.70 is at the $94.40 area. This level has held as support in the last few months. A break below would see the 52-week low at $92.22 as next support, followed by $89.85.
14:05 EDTMCDEarnings Preview: McDonald's to return up to $20B to investors from 2014-2016
Subscribe for More Information
12:41 EDTTSMIntel advances after analyst predicts mobile unit rebound coming
Shares of Intel (INTC) are advancing in a down market after Wells Fargo wrote that the company's mobile chip business could rebound significantly in coming quarters. WHAT'S NEW: Intel's mobile chip business could boost the company's growth and even enable it to beat earnings expectations, Wells Fargo wrote in a note to investors today. The chip maker's shipments of 4G modems should start rising significantly in the third quarter or fourth quarter of this year, the firm stated. The company has probably won some deals to provide LTE modems for smartphones and Samsung is likely one of the chip maker's initial customers, the firm wrote. Broadcom's (BRCM) decision to exit the baseband market probably improved Intel's position in the 4G market, Wells Fargo contended. Meanwhile, Intel said that by this year's holiday season, it should be ready to launch chips for mobile devices that are smaller than those of a key competitor, TSMC (TSM), Wells noted. Sales generated by Intel's mobile and communications unit may have bottomed last quarter or could do so during the current quarter, the firm believes. The unit's operating losses are likely to drop throughout this year, before falling sharply in the quarter ended March 2015, Wells estimated. The unit may approach break even by the end of 2015, the firm added. Wells kept an Outperform rating on the stock. WHAT'S NOTABLE: On July 15, Intel reported stronger than expected results for its quarter ended in June. PRICE ACTION: In early afternoon trading, Intel rose 43c, or 1.3%, to $34.13.
11:00 EDTMCDStarbucks China says one of its suppliers got meat from Husi, Bloomberg reports
Subscribe for More Information
10:42 EDTATHNOptions with decreasing implied volatility
Subscribe for More Information
09:10 EDTMCDOn The Fly: Pre-market Movers
HIGHER: Allergan (AGN), up 0.5% after Q2 results, FY14 outlook beat expectations and the company announces plans to reduce workforce by about 1,500 employees as part of restructuring. Also, Valeant (VRX) announced it has contacted both the SEC and Canadian financial authorities regarding Allergan's "apparent attempt to mislead investors and manipulate the market for Valeant common shares by continuing to make false and misleading statements regarding Valeant's business"... Extreme Networks (EXTR), up 13% after raising Q4 EPS, revenue view... Gas Natural (EGAS), up 6% after confirming it rejected $13 per share unsolicited offer from Algonquin Power... EMC (EMC), up 4.5% after the WSJ says Elliot Management took a stake of over $1B in the firm and plans to push the company to break itself up... GoPro, (GPRO), up 2.8% after initiated at several firms including Citigroup, Barclays and JPMorgan... Kandi Technologies (KNDI), up 6% after China Daily said China will not to waive a sales tax on electric cars made by foreign companies. Tesla (TSLA) is down 1% following the report. UP AFTER EARNINGS: Halliburton (HAL), up 0.5%... LOWER: Reynolds American (RAI), down 2.3% after a Florida jury hit the company with $23.6B in punitive damages in a lawsuit filed by the widow of a longtime smoker. Shares of fellow tobacco companies also fell after the jury decision, as Lorillard (LO) fell 2% and Altria (MO) slid 1.6%... Yum! Brands (YUM), down 2% after AP reported that a Shanghai TV station said a food supplier sold expired beef and chicken to the company's KFC brand in China along with to McDonald's (MCD), which is down 0.7%. DOWN AFTER EARNINGS: PetMed Express (PETS), down 2.4%... Hasbro (HAS), down 1.3%.
07:49 EDTATHNathenahealth shares should be bought on weakness, says Stifel
Stifel believes that athenahealth reported solid Q2 results, and the firm thinks the company has a number of upcoming positive catalysts. The firm believes that the company is in the midst of a positive turning point and keeps a $155 price target and Buy rating.
07:11 EDTRHHBYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
06:43 EDTRHHBYGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
06:22 EDTMCDMcDonald's July weekly volatility elevated into Q2
Subscribe for More Information
05:59 EDTMCDMcDonald's, KFC face expired food scandal in China, AP reports
Subscribe for More Information
05:54 EDTMPELStocks with implied volatility movement; MPEL MCP
Subscribe for More Information
July 20, 2014
15:42 EDTRHHBYRoche not looking for big acquisitions, Reuters says
Subscribe for More Information
12:58 EDTTSMTSMC could drop over 10%, Barron's says
Subscribe for More Information
July 18, 2014
12:59 EDTMPELMelco Crown July weekly & August calls active
Subscribe for More Information
11:07 EDTATHNathenahealth defended, sell-off overdone, says Leerink
Subscribe for More Information
07:20 EDTTSMLG Display added to Asia Focus List, TSMC removed at JPMorgan
Subscribe for More Information
July 17, 2014
17:42 EDTRHHBYCepheid says Roche patent suit will not have material adverse impact on results
Subscribe for More Information
16:12 EDTATHNathenahealth trades up after earnings, levels to watch
Subscribe for More Information
16:09 EDTATHNathenahealth sees FY14 EPS 98c -$1.10, consensus $1.04
Sees FY14 revenue $725M -$755M, consensus $741.02M.
16:06 EDTATHNathenahealth reports Q2 EPS 32c, consensus 22c
Subscribe for More Information
15:26 EDTATHNNotable companies reporting after market close
Subscribe for More Information
14:40 EDTATHNathenahealth July 129 straddle priced for 8.7% move into Q2
Subscribe for More Information
14:30 EDTTSMFujitsu to exit chip making, sell plants to ON Semi, United Micro, Nikkei says
Subscribe for More Information
06:43 EDTTSMTSMC expects to lose out to competitors in 14/16nm segment, DigiTimes says
Subscribe for More Information
July 16, 2014
11:23 EDTRHHBYRoche Alzheimer drug shows mixed results in trial, NYT says
Subscribe for More Information
10:48 EDTTSMTSMC falls, levels to watch
Subscribe for More Information
10:00 EDTTSMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTSYTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:08 EDTTSMTSMC downgraded to Negative from Neutral at Susquehanna
06:26 EDTRHHBYBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
06:18 EDTTSMTSMC volatility increases as shares trade near 14-year high
Subscribe for More Information
05:49 EDTTSMStocks with implied volatility movement; SDS TSM
Subscribe for More Information
05:33 EDTSYTSyngenta upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
July 15, 2014
07:29 EDTTSMASML Q2 results could miss expectations, says RBC Capital
Subscribe for More Information
05:37 EDTRHHBYGenentech Avastin granted priority review by FDA
Subscribe for More Information
July 14, 2014
14:20 EDTATHNathenahealth July volatility increases into Q2 and outlook
Subscribe for More Information
11:20 EDTRHHBYExelixis seen as potential target for Roche, TheStreet says
Subscribe for More Information
July 10, 2014
10:02 EDTRHHBYRoche unit, Merck KGaA to develop companion test for cancer treatment
Ventana Medical Systems, a member of the Roche Group (RHHBY), announced it has entered into an agreement with Merck KGaA (MKGAY), which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic for an undisclosed target using Ventana's proprietary diagnostic assays.
08:55 EDTATHNathenahealth volatility increases into Q2 and outlook
Subscribe for More Information
07:54 EDTTSMTSMC begins shipping microprocessors to Apple, WSJ reports
TSMC (TSM) has begun shipping microprocessors to Apple (AAPL) for use in smartphones and tablets, reports the Wall Street Journal. According to people familiar with the matter, TSMC began shipping the microprocessors in Q2 and agreed to work together on more advanced chips next year. Reference Link
07:11 EDTAETAetna, WellPoint top large-cap Managed Care picks at Jefferies
Jefferies calls Aetna (AET) and WellPoint (WLP) its favorite large-cap picks in the Managed Care space, with Health Net (HNT) its favored name in the small to mid-cap space. The firm believes the market is already expecting strong Q2 results from the sector, and it downgraded UnitedHealth (UNH) to Hold from Buy on valuation and below-peer earnings growth. Jefferies has Buy ratings on Aetna, Health Net, Molina Healthcare (MOH) and WellPoint.
06:23 EDTAETHealth insurers moving away from fee for service model, NY Times reports
Subscribe for More Information
July 9, 2014
12:56 EDTAETAetna names Harold L. Paz, M.D., M.S. as Chief Medical Officer
Subscribe for More Information
06:15 EDTTSMTSMC to speed up development of 19nm process, DigiTimes reports
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use